These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39277630)

  • 1. Short-term efficacy of photobiomodulation in early and intermediate age-related macular degeneration: the PBM4AMD study.
    Nassisi M; Mainetti C; Paparella GR; Belloni Baroni L; Milella P; Leone G; Galli D; Pozzo Giuffrida F; Dell'Arti L; Mapelli C; Casalino G; Viola F
    Eye (Lond); 2024 Sep; ():. PubMed ID: 39277630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHOTOBIOMODULATION THERAPY FOR LARGE SOFT DRUSEN AND DRUSENOID PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION: A Single-Center Prospective Pilot Study.
    Benlahbib M; Cohen SY; Torrell N; Colantuono D; Crincoli E; Amoroso F; Semoun O; Jung C; Souied EH
    Retina; 2023 Aug; 43(8):1246-1254. PubMed ID: 37027819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.
    Markowitz SN; Devenyi RG; Munk MR; Croissant CL; Tedford SE; Rückert R; Walker MG; Patino BE; Chen L; Nido M; Tedford CE
    Retina; 2020 Aug; 40(8):1471-1482. PubMed ID: 31404033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration.
    Merry GF; Munk MR; Dotson RS; Walker MG; Devenyi RG
    Acta Ophthalmol; 2017 Jun; 95(4):e270-e277. PubMed ID: 27989012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
    Allingham MJ; Mettu PS; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photobiomodulation for non-exudative age-related macular degeneration.
    Henein C; Steel DH
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013029. PubMed ID: 34097768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding Light on Photobiomodulation Therapy for Age-Related Macular Degeneration: A Narrative Review.
    Fantaguzzi F; Tombolini B; Servillo A; Zucchiatti I; Sacconi R; Bandello F; Querques G
    Ophthalmol Ther; 2023 Dec; 12(6):2903-2915. PubMed ID: 37768527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration.
    Borrelli E; Coco G; Pellegrini M; Mura M; Ciarmatori N; Scorcia V; Carnevali A; Lucisano A; Borselli M; Rossi C; Reibaldi M; Ricardi F; Vagge A; Nicolò M; Forte P; Cartabellotta A; Hasanreisoğlu M; Kesim C; Demirel S; Yanık Ö; Bernabei F; Rothschild PR; Farrant S; Giannaccare G
    Ophthalmol Ther; 2024 Nov; 13(11):2855-2868. PubMed ID: 39271642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration.
    Wu Z; Ayton LN; Luu CD; Guymer RH
    JAMA Ophthalmol; 2015 Apr; 133(4):442-8. PubMed ID: 25632841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1).
    Lek JJ; Brassington KH; Luu CD; Chen FK; Arnold JJ; Heriot WJ; Durkin SR; Chakravarthy U; Guymer RH;
    Ophthalmol Retina; 2017; 1(3):227-239. PubMed ID: 31047426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies.
    Feltgen N; Ogura Y; Boscia F; Holz FG; Korobelnik JF; Brown DM; Heier JS; Stemper B; Rittenhouse KD; Asmus F; Ahlers C; Vitti R; Saroj N; Mitchell P
    Ophthalmol Retina; 2019 Jul; 3(7):553-560. PubMed ID: 31277796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for conversion to neovascular age-related macular degeneration based on longitudinal morphologic and visual acuity data.
    Friberg TR; Bilonick RA; Brennen PM
    Ophthalmology; 2012 Jul; 119(7):1432-7. PubMed ID: 22551740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
    Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal Sensitivity Using Microperimetry in Age-Related Macular Degeneration in an Amish Population.
    Nittala MG; Velaga SB; Hariri A; Pfau M; Birch DG; Haines J; Pericak-Vance MA; Stambolian D; Sadda SR
    Ophthalmic Surg Lasers Imaging Retina; 2019 Sep; 50(9):e236-e241. PubMed ID: 31589764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Parravano M; Oddone F; Tedeschi M; Schiano Lomoriello D; Chiaravalloti A; Ripandelli G; Varano M
    Retina; 2009 Mar; 29(3):329-34. PubMed ID: 19092732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Visual Function Measures with Drusen Volume in Early Stages of Age-Related Macular Degeneration.
    Pondorfer SG; Wintergerst MWM; Gorgi Zadeh S; Schultz T; Heinemann M; Holz FG; Finger RP
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):55. PubMed ID: 32232348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
    Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
    Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome.
    Chung WH; van Dijk EH; Mohabati D; Dijkman G; Yzer S; de Jong EK; Fauser S; Schlingemann RO; Hoyng CB; Boon CJ
    Clin Ophthalmol; 2017; 11():63-70. PubMed ID: 28053502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.
    Boyer D; Hu A; Warrow D; Xavier S; Gonzalez V; Lad E; Rosen RB; Do D; Schneiderman T; Ho A; Munk MR; Jaffe G; Tedford SE; Croissant CL; Walker M; Rückert R; Tedford CE
    Retina; 2024 Mar; 44(3):487-497. PubMed ID: 37972955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.